The HIV+Hepatitis Policy Institute, the Diabetes Leadership Council and the Diabetes Patient Advocacy Coalition filed the lawsuit Aug. 30 in the U.S. District Court for the District of Columbia on behalf of more than 42 million Americans.
HHS’ 2021 Notice of Benefit and Payment Parameters rule allows insurers and PBMs to have the policies, known as copay accumulator adjustment programs.
The advocacy groups argue that these policies increase costs for patients and violate cost-sharing caps set under the ACA, allowing insurers to “double dip” and receive payments from both the patient and drug manufacturers in the form of copay assistance.
Editor’s note: Becker’s has reached out to HHS for comment on the lawsuit and will update the article when more information is available.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.